Who Paid My Doc
Lakhmir Chawla
Critical Care Medicine Washington, DC Medical Doctor
NPI 1124087721 CMS profile 142153
900 23Rd St Nw, Suite G- 2092, Washington, DC 20037
General payments
$441,228
Research payments
$0
Ownership & investment interest
$606,137
Through program year 2025, Lakhmir Chawla of Washington, DC is reported in the CMS Open Payments database as having received $441,228 across 51 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $606,137 across 5 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
11 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $247 | 3 | |
| 2024 | General | $107,386 | 4 | |
| 2023 | General | $135,000 | 9 | |
| 2022 | General | $142,255 | 21 | |
| 2021 | General | $27,642 | 5 | |
| 2020 | General | $21,099 | 2 | |
| 2019 | General | $7,599 | 7 | |
| 2024 | Ownership | $242,795 | 1 | |
| 2023 | Ownership | $55,971 | 1 | |
| 2022 | Ownership | $224,222 | 1 | |
| 2021 | Ownership | $83,150 | 2 |
Beside peers
- Lakhmir Chawla
- Critical Care Medicine median
- Middle half of Critical Care Medicine
- National median
In program year 2025, general payments to Lakhmir Chawla were reported at $247. Among 2,664 Critical Care Medicine profiles paid that year, the median was $189 and the middle half received between $59 and $844.
Show as a table
| Year | Lakhmir Chawla | Critical Care Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $7,599 | $149 | $51–$535 | $163 |
| 2020 | $21,099 | $110 | $30–$325 | $114 |
| 2021 | $27,642 | $125 | $34–$403 | $132 |
| 2022 | $142,255 | $157 | $49–$582 | $149 |
| 2023 | $135,000 | $162 | $56–$621 | $160 |
| 2024 | $107,386 | $168 | $53–$634 | $164 |
| 2025 | $247 | $189 | $59–$844 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
51 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Critical Care Medicine in District of Columbia
Tunay Kuru
Critical Care Medicine · Washington, DC
Vivek Jain
Critical Care Medicine · Washington, DC
Kellen Mulhern
Critical Care Medicine · Washington, DC
Jacob Collen
Critical Care Medicine · Washington, DC
Danielle Davison
Critical Care Medicine · Washington, DC
Andrew Hill
Critical Care Medicine · Washington, DC
Related records
Critical Care Medicine in District of Columbia
Practitioners in the same specialty and state, ranked by reported value.
All Critical Care Medicine
Everyone recorded under this specialty, nationwide.
Doctors in District of Columbia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.